Open Access
- 29 June 2024
- journal article
- research article
- Published by Doc Design and Informatics Co. Ltd. in Klimik Dergisi/Klimik Journal
- Vol. 37 (2) , 146-148
Abstract
The risk of thromboembolic pathologies increases in COVID-19 cases who have risk factors for poor prognosis and are prone to have a severe clinical course. Few cases of cerebral sinus vein thrombosis (CSVT) accompanying COVID-19 have been reported. We present a patient who developed CSVT during COVID-19 without a known risk factor for thrombosis but was found to have a genetic mutation of the prothrombin 20210 G/A gene, which is a congenital thrombophilia risk factor. We aim to emphasize the importance of investigating additional pathologies in thromboembolic events during COVID-19 in cases without known comorbidities.Keywords
This publication has 9 references indexed in Scilit:
- Understanding COVID-19-associated coagulopathyNature Reviews Immunology, 2022
- Case reports of cerebral sinus venous thrombosis in COVID-19 patientsThe Egyptian Journal of Neurology, Psychiatry and Neurosurgery, 2021
- American Society of Hematology 2021 guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19Blood Advances, 2021
- Cerebral venous thrombosis and severe acute respiratory syndrome coronavirus‐2 infection: A systematic review and meta‐analysisEuropean Journal of Neurology, 2021
- Cerebral Venous Sinus Thrombosis in COVID-19 Infection: A Case Series and Review of The LiteratureJournal of Stroke and Cerebrovascular Diseases, 2021
- Cerebral Venous Sinus Thrombosis in the COVID-19 PandemicJournal of Neuro-Ophthalmology, 2020
- Prevention, Diagnosis, and Treatment of VTE in Patients With Coronavirus Disease 2019Chest, 2020
- Clinical, molecular, and epidemiological characterization of the SARS-CoV-2 virus and the Coronavirus Disease 2019 (COVID-19), a comprehensive literature reviewDiagnostic Microbiology and Infectious Disease, 2020
- Cerebral sinus venous thrombosisJournal of Neurosciences in Rural Practice, 2013